HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Julie C Friedland Selected Research
Julie C Friedland Research Topics
Disease
5
Neoplasms (Cancer)
02/2014 - 01/2009
2
Breast Neoplasms (Breast Cancer)
02/2014 - 10/2007
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2013 - 12/2012
1
Melanoma (Melanoma, Malignant)
01/2022
1
Inflammatory Breast Neoplasms
02/2014
1
Prostatic Neoplasms (Prostate Cancer)
01/2013
1
Lung Neoplasms (Lung Cancer)
12/2012
1
Brain Injuries (Brain Injury)
06/2004
1
Ischemia
06/2004
1
Traumatic Brain Injuries (Traumatic Brain Injury)
06/2004
Drug/Important Bio-Agent (IBA)
4
STA 9090
IBA
02/2014 - 12/2012
4
Molecular Chaperones (Chaperone, Molecular)
IBA
02/2014 - 12/2012
2
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2022 - 02/2014
2
Heat-Shock Proteins (Heat-Shock Protein)
IBA
02/2014 - 01/2013
2
Proteins (Proteins, Gene)
FDA Link
02/2014 - 01/2013
1
ulixertinib
IBA
01/2022
1
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
01/2022
1
tyrosine receptor (receptor, tyrosine)
IBA
02/2014
1
Lapatinib (GW572016)
FDA Link
02/2014
1
Hormones (Hormone)
IBA
02/2014
1
Transcription Factors (Transcription Factor)
IBA
02/2014
1
Crizotinib
IBA
04/2013
1
Phosphotransferases (Kinase)
IBA
04/2013
1
Anaplastic Lymphoma Kinase
IBA
04/2013
1
Androgens
IBA
01/2013
1
Androgen Receptors (Androgen Receptor)
IBA
01/2013
1
Integrins
IBA
01/2009
1
Integrin alpha6beta4
IBA
10/2007
1
salicylhydroxamic acid (SHAM)
IBA
06/2004
1
Glycogen
IBA
06/2004
Therapy/Procedure
4
Therapeutics
01/2022 - 12/2012